CoChat

The influences of vitamin D and omega-3 co-supplementation on clinical, metabolic and genetic parameters in women with polycystic ovary syndrome

Jamilian, Mehri, Samimi, Mansooreh, Mirhosseini, Naghmeh, Afshar Ebrahimi, Faraneh, Aghadavod, Esmat, Talaee, Rezavan, Jafarnejad, Sadegh, Hashemi Dizaji, Shahrzad, Asemi, Zatollah · 2018 · Journal of Affective Disorders
Cited by 89

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

OBJECTIVE The aim of this study was to evaluate the effect of the co-administration of vitamin D and omega-3 fatty acid on clinical, metabolic and genetic parameters in women with polycystic ovary syndrome (PCOS). METHODS This randomized, double-blinded, placebo-controlled clinical trial was conducted on 60 subjects, aged 18-40 years old with PCOS. Subjects were randomly allocated to take either 50,000 IU vitamin D every 2 weeks plus 2000 mg/day omega-3 fatty acid from fish oil (n = 30) or placebo (n = 30) for 12 weeks. Gene expression analysis of inflammatory cytokines was conducted on peripheral blood mononuclear cells (PBMCs) of PCOS women using RT-PCR method. RESULTS Vitamin D and omega -3 fatty acid co-supplementation significantly decreased serum total testosterone levels (-0.2 ± 0.5 vs. + 0.1 ± 0.4 ng/mL, P = 0.02) compared with the placebo. In addition, vitamin D and omega-3 fatty acid co-supplementation resulted in a significant improvement in beck depression inventory (-1.4 ± 1.6 vs. -0.5 ± 0.6, P = 0.01), general health questionnaire scores (-4.5 ± 4.3 vs. -1.9 ± 2.3, P = 0.005) and depression anxiety and stress scale scores (-5.0 ± 5.1 vs. -2.3 ± 3.5, P = 0.01) compared with the placebo. Additionally, vitamin D and omega-3 fatty acid co-administration significantly decreased serum high-sensitivity C-reactive protein (hs-CRP) (-1.2 ± 1.9 vs. + 0.1 ± 0.7 mg/L, P = 0.001) and malondialdehyde (MDA) levels (-0.4 ± 0.4 vs. + 0.2 ± 0.6 µmol/L, P < 0.001), and significantly increased plasma total antioxidant capacity (TAC) levels (+ 114.6 ± 122.2 vs. -2.4 ± 168.2 mmol/L, P = 0.003) compared with the placebo. Results of RT-PCR demonstrated that vitamin D and omega-3 fatty acid co-supplementation significantly downregulated gene expression of interleukin-1 (IL-1) (P = 0.03), and upregulated vascular endothelial growth factor (VEGF) (P = 0.004) in PBMCs of subjects with PCOS, when compared with placebo. CONCLUSIONS Overall, the co-administration of vitamin D and omega-3 fatty acid for 12 weeks had beneficial effects on mental health parameters, serum total testosterone, hs-CRP, plasma TAC and MDA levels, and gene expression of IL-1 and VEGF among women with PCOS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jad.2018.05.027

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Research works printed but not linked: 38

  1. Azadi-Yazdi, 2017, The effect of vitamin D supplementation on the androgenic profile in patients with polycystic ovary syndrome: a systematic review and meta-analysis of clinical trials, Horm. Metab. Res., 49, 174, 10.1055/s-0043-103573 · DOI · Paper page
  2. Bargiota, 2012, The effects of old, new and emerging medicines on metabolic aberrations in PCOS, Ther. Adv. Endocrinol. Metab., 3, 27, 10.1177/2042018812437355 · DOI · Paper page
  3. Beck, 1961, An inventory for measuring depression, Arch. Gen. Psychiatry, 4, 561, 10.1001/archpsyc.1961.01710120031004 · DOI · Paper page
  4. Benzie, 1996, The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay, Anal. Biochem., 239, 70, 10.1006/abio.1996.0292 · DOI · Paper page
  5. Beutler, 1985, Plasma glutathione in health and in patients with malignant disease, J. Lab. Clin. Med., 105, 581
  6. Bischoff-Ferrari, 2006, Effect of cholecalciferol plus calcium on falling in ambulatory older men and women: a 3-year randomized controlled trial, Arch. Intern. Med., 166, 424
  7. Bozzatello, 2016, Supplementation with omega-3 fatty acids in psychiatric disorders: a review of literature data, J. Clin. Med., 5, 10.3390/jcm5080067 · DOI · Paper page
  8. Cetinkalp, 2009, The effect of 1alpha,25(OH)2D3 vitamin over oxidative stress and biochemical parameters in rats where Type 1 diabetes is formed by streptozotocin, J. Diab. Compl., 23, 401, 10.1016/j.jdiacomp.2008.09.005 · DOI
  9. Cooney, 2017, Depression and anxiety in polycystic ovary syndrome: etiology and treatment, Curr. Psychiatry Rep., 19, 83, 10.1007/s11920-017-0834-2 · DOI · Paper page
  10. Dunkley, 2008, A rapid Percoll gradient procedure for preparation of synaptosomes, Nat. Protoc., 3, 1718, 10.1038/nprot.2008.171 · DOI · Paper page
  11. Escobar-Morreale, 2011, Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysis, Fertil. Steril., 95, e1041
  12. Gambineri, 2002, Obesity and the polycystic ovary syndrome, Int. J. Obes. Relat. Metab. Disord., 26, 883, 10.1038/sj.ijo.0801994 · DOI · Paper page
  13. Garg, 2015, Effect of vitamin D supplementation on insulin kinetics and cardiovascular risk factors in polycystic ovarian syndrome: a pilot study, Endocr. Connect., 4, 108, 10.1530/EC-15-0001 · DOI · Paper page
  14. Goldberg, 1979, A scaled version of the General Health Questionnaire, Psychol. Med., 9, 139, 10.1017/S0033291700021644 · DOI · Paper page
  15. Gonzalez, 2012, Hyperandrogenism sensitizes leukocytes to hyperglycemia to promote oxidative stress in lean reproductive-age women, J. Clin. Endocrinol. Metab., 97, 2836, 10.1210/jc.2012-1259 · DOI · Paper page
  16. Gruber, 2008, 1,25(OH)2-vitamin D3 inhibits proliferation and decreases production of monocyte chemoattractant protein-1, thrombopoietin, VEGF, and angiogenin by human annulus cells in vitro, Spine (Phila Pa 1976), 33, 755, 10.1097/BRS.0b013e3181695d59 · doi:10.1097/brs.0b013e3181695d59
  17. Hahn, 2006, Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome, Exp. Clin. Endocrinol. Diab., 114, 577, 10.1055/s-2006-948308 · DOI · Paper page
  18. Hassan Eftekhari, 2013, Effect of conjugated linoleic acid and omega-3 fatty acid supplementation on inflammatory and oxidative stress markers in atherosclerotic patients, ARYA Atheroscler., 9, 311
  19. Hatch, 1981, Hirsutism: implications, etiology, and management, Am. J. Obstet. Gynecol., 140, 815, 10.1016/0002-9378(81)90746-8 · DOI · Paper page
  20. Irani, 2015, Vitamin D supplementation decreases tgf-beta1 bioavailability in PCOS: a randomized placebo-controlled trial, J. Clin. Endocrinol. Metab., 100, 4307, 10.1210/jc.2015-2580 · DOI · Paper page
  21. Jain, 2013, Vitamin D upregulates glutamate cysteine ligase and glutathione reductase, and GSH formation, and decreases ROS and MCP-1 and IL-8 secretion in high-glucose exposed U937 monocytes, Biochem. Biophys. Res. Commun., 437, 7, 10.1016/j.bbrc.2013.06.004 · DOI · Paper page
  22. Janero, 1990, Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury, Free Radic. Biol. Med., 9, 515, 10.1016/0891-5849(90)90131-2 · DOI · Paper page
  23. Karakas, 2016, Changes in plasma metabolites and glucose homeostasis during omega-3 polyunsaturated fatty acid supplementation in women with polycystic ovary syndrome, BBA Clin., 5, 179, 10.1016/j.bbacli.2016.04.003 · DOI · Paper page
  24. Krul-Poel, 2013, The role of vitamin D in metabolic disturbances in polycystic ovary syndrome: a systematic review, Eur. J. Endocrinol., 169, 853, 10.1530/EJE-13-0617 · DOI · Paper page
  25. Maktabi, 2018, Magnesium-zinc-calcium-vitamin D co-supplementation improves hormonal profiles, biomarkers of inflammation and oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial, Biol. Trace Elem. Res., 182, 21, 10.1007/s12011-017-1085-0 · DOI
  26. Nasiri, 2015, Abdominal obesity can induce both systemic and follicular fluid oxidative stress independent from polycystic ovary syndrome, Eur J Obstet. Gynecol. Reprod. Biol., 184, 112, 10.1016/j.ejogrb.2014.11.008 · DOI
  27. Pan, 2002, Quantification of Doppler signal in polycystic ovary syndrome using three-dimensional power Doppler ultrasonography: a possible new marker for diagnosis, Hum. Reprod., 17, 201, 10.1093/humrep/17.1.201 · DOI
  28. Setji, 2014, Polycystic ovary syndrome: update on diagnosis and treatment, Am. J. Med., 127, 912, 10.1016/j.amjmed.2014.04.017 · DOI
  29. Smogorzewski, 2001, Central nervous dysfunction in uremia, Am. J. Kidney Dis., 38, S122, 10.1053/ajkd.2001.27419 · DOI
  30. Stumpf, 1982, Brain target sites for 1,25-dihydroxyvitamin D3, Science, 215, 1403, 10.1126/science.6977846 · DOI · Paper page
  31. Tal, 2015, The emerging role of angiogenic factor dysregulation in the pathogenesis of polycystic ovarian syndrome, Semin. Reprod. Med., 33, 195, 10.1055/s-0035-1552582 · DOI
  32. Tatsch, 2011, A simple and inexpensive automated technique for measurement of serum nitrite/nitrate, Clin. Biochem., 44, 348, 10.1016/j.clinbiochem.2010.12.011 · DOI · Paper page
  33. Teegarden, 2009, Vitamin D: emerging new roles in insulin sensitivity, Nutr. Res. Rev., 22, 82, 10.1017/S0954422409389301 · DOI · Paper page
  34. Velija-Asimi, 2014, Evaluation of the association of vitamin D deficiency with gonadotropins and sex hormone in obese and non-obese women with polycystic ovary syndrome, Med. Glas. (Zenica), 11, 170
  35. Vieth, 2007, The urgent need to recommend an intake of vitamin D that is effective, Am. J. Clin. Nutr., 85, 649, 10.1093/ajcn/85.3.649 · DOI · Paper page
  36. Vincent, 2007, Oxidative stress and potential interventions to reduce oxidative stress in overweight and obesity, Diab. Obes. Metab., 9, 813, 10.1111/j.1463-1326.2007.00692.x · DOI · Paper page
  37. Wehr, 2011, Vitamin D-associated polymorphisms are related to insulin resistance and vitamin D deficiency in polycystic ovary syndrome, Eur. J. Endocrinol., 164, 741, 10.1530/EJE-11-0134 · DOI · Paper page
  38. Zaidi, 1995, Ovarian stromal blood flow in women with polycystic ovaries – a possible new marker for diagnosis?, Hum. Reprod., 10, 1992, 10.1093/oxfordjournals.humrep.a136222 · DOI · Paper page

Cited by

See all 89

Metadata

Authors
Jamilian, M., Samimi, M., Mirhosseini, N., Afshar Ebrahimi, F., Aghadavod, E., Talaee, R., Jafarnejad, S., Hashemi Dizaji, S., & Asemi, Z.
Venue
Journal of Affective Disorders
Publisher
Elsevier BV
Published
2018-10
Volume
238
Pages
32-38
ISSN
0165-0327 (ISSN-L)
OpenAlex
W2804955101
Cited by
89
References
12
FWCI
8.53
Type
journal article
Language
en
Open access
closed
Licence
www.elsevier.com/tdm/userlicense/1.0/ (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The influences of vitamin D and omega-3 co-supplementation on clinical, metabolic and genetic parameters in women with polycystic ovary syndrome. https://app.cochat.ai/papers/10.1016/j.jad.2018.05.027
The paper
Jamilian, M., Samimi, M., Mirhosseini, N., Afshar Ebrahimi, F., Aghadavod, E., Talaee, R., Jafarnejad, S., Hashemi Dizaji, S., & Asemi, Z. (2018). The influences of vitamin D and omega-3 co-supplementation on clinical, metabolic and genetic parameters in women with polycystic ovary syndrome. Journal of Affective Disorders. https://doi.org/10.1016/j.jad.2018.05.027

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.